Holds 4 active US DMFs for cilastatin, filing since 2008. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 12 markets.
Holds 4 active US DMFs for cilastatin, filing since 2008. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 12 markets.
Holds one active US DMF and one valid CEP for cilastatin, filing since 2025. Its 2019 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for cilastatin, filing since 2006. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.
Holds 2 active US DMFs for cilastatin, filing since 2014. Its GMP is recognised in 5 markets.
Holds one active US DMF for cilastatin, filing since 2009. Its GMP is recognised in 2 markets.
Registered with SFDA (Saudi Arabia) for cilastatin. Its GMP is recognised in 16 markets.
Registered with SFDA (Saudi Arabia) for cilastatin. Its GMP is recognised in 3 markets.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Chat with Fred, your AI analystContract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for cilastatin and what filings they hold.
Chat with Fred, your AI analystFixed-dose combinations containing cilastatin. Each page leads with the verified API makers of every component.